Sona Nanotech, Inc (TSE:SONA) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sona Nanotech, Inc. has secured a total of $40,000 in grant funding to enhance its intellectual property portfolio, with contributions from the NRC IRAP and Springboard Atlantic programs. The funds will aid in developing a robust IP strategy and the finalization of a provisional patent for a novel cancer drug delivery concept. The company’s CEO, David Regan, acknowledges the importance of this support for advancing their proprietary gold nanorod technology in cancer research and development.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.